Pengrong Yan

5PUBLICATIONS
32CO-AUTHORS
Molecular targetsProteins and peptidesMajor global burdens of diseaseOther law and legal studies not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 26, 2021
Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.

Suhasini Joshi, Erica DaGama Gomes, Tai Wang

|Aug 04, 2021
Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.

Alexander Bolaender, Danuta Zatorska, Huazhong He

|Jan 18, 2020
The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction.

Maria Carmen Inda, Suhasini Joshi, Tai Wang

|Nov 24, 2019
Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.

Fan Sun, Liwen Li, Pengrong Yan

|Sep 25, 2019
Reply to 'H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines'.

Mariano J Alvarez, Pengrong Yan, Mary L Alpaugh

Pageof 1